Found: 18
Select item for more details and to access through your institution.
2781. Statistical Modeling to Predict Maternal RSV Vaccine Efficacy from Neutralizing Titers.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S982, doi. 10.1093/ofid/ofz360.2458
- By:
- Publication type:
- Article
2755. Phase 1/2, First-in-Human Study of the Safety, Tolerability, and Immunogenicity of an RSV Prefusion F-Based Subunit Vaccine Candidate.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S970, doi. 10.1093/ofid/ofz360.2432
- By:
- Publication type:
- Article
Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults.
- Published in:
- Infectious Diseases & Therapy, 2023, v. 12, n. 9, p. 2241, doi. 10.1007/s40121-023-00863-5
- By:
- Publication type:
- Article
Neutralization of Omicron BA.1, BA.2, and BA.3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-30681-1
- By:
- Publication type:
- Article
Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine against XBB.1.5, BA.2.86, and JN.1 Sublineages: A Phase 2/3 Trial.
- Published in:
- Vaccines, 2024, v. 12, n. 7, p. 734, doi. 10.3390/vaccines12070734
- By:
- Publication type:
- Article
Safety and Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine in Individuals ≥12 Years Old: A Phase 2/3 Trial.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 118, doi. 10.3390/vaccines12020118
- By:
- Publication type:
- Article
CDllc<sup>+</sup> Cells Modulate Pulmonary Immune Responses by Production of Indoleamine 2,3-Dioxygenase.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2004, v. 30, n. 3, p. 311, doi. 10.1165/rcmb.2003-0268OC
- By:
- Publication type:
- Article
Modeling SARS-CoV-2: Comparative Pathology in Rhesus Macaque and Golden Syrian Hamster Models.
- Published in:
- Toxicologic Pathology, 2022, v. 50, n. 3, p. 280, doi. 10.1177/01926233211072767
- By:
- Publication type:
- Article
Immunogenicity and Safety of a Third COVID-19 BNT162b2 mRNA Vaccine Dose in 5- to 11-Year Olds.
- Published in:
- Journal of the Pediatric Infectious Diseases Society, 2023, v. 12, n. 4, p. 234, doi. 10.1093/jpids/piad015
- By:
- Publication type:
- Article
A Bivalent Omicron-BA.4/BA.5-Adapted BNT162b2 Booster in ≥12-Year-Olds.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 5, p. 1194, doi. 10.1093/cid/ciad718
- By:
- Publication type:
- Article
Safety and Immunogenicity of Bivalent RSVpreF Vaccine Coadministered With Seasonal Inactivated Influenza Vaccine in Older Adults.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 5, p. 1360, doi. 10.1093/cid/ciad707
- By:
- Publication type:
- Article
BNT162b2-elicited neutralization of Delta plus, Lambda, Mu, B.1.1.519, and Theta SARS-CoV-2 variants.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00462-4
- By:
- Publication type:
- Article
The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00313-8
- By:
- Publication type:
- Article
Respiratory Syncytial Virus Prefusion F Vaccination: Antibody Persistence and Revaccination.
- Published in:
- Journal of Infectious Diseases, 2024, v. 230, n. 4, p. e905, doi. 10.1093/infdis/jiae185
- By:
- Publication type:
- Article
Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine With and Without Adjuvant in Healthy Older Adults.
- Published in:
- Journal of Infectious Diseases, 2022, v. 226, n. 12, p. 2054, doi. 10.1093/infdis/jiac189
- By:
- Publication type:
- Article
Phase 1/2 Randomized Study of the Immunogenicity, Safety, and Tolerability of a Respiratory Syncytial Virus Prefusion F Vaccine in Adults With Concomitant Inactivated Influenza Vaccine.
- Published in:
- Journal of Infectious Diseases, 2022, v. 225, n. 12, p. 2056, doi. 10.1093/infdis/jiab611
- By:
- Publication type:
- Article
Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F Vaccine When Coadministered With a Tetanus, Diphtheria, and Acellular Pertussis Vaccine.
- Published in:
- Journal of Infectious Diseases, 2022, v. 225, n. 12, p. 2077, doi. 10.1093/infdis/jiab505
- By:
- Publication type:
- Article
A Randomized Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine.
- Published in:
- 2022
- By:
- Publication type:
- journal article